WWP1 ubiquitinates HER4 to mediate both proteasomal and lysosomal degradation[151]
WWP1 ubiquitinates HER4 to mediate both proteasomal and lysosomal degradation[151]. the HER3-targeted therapies are licensed for utilization in clinical malignancy…